Growth Metrics

Jazz Pharmaceuticals (JAZZ) EPS (Weighted Average and Diluted) (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Jazz Pharmaceuticals 14.35 Bn 12.51 Bn 934.80 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 32.63%
Dec 31, 2025 -18.14%
Sep 30, 2025 134.75%
Jun 30, 2025 -672.37%
Mar 31, 2025 -150.33%
Dec 31, 2024 -11.70%
Sep 30, 2024 37.35%
Jun 30, 2024 1,182.61%
Mar 31, 2024 -116.08%
Dec 31, 2023 -33.18%
Sep 30, 2023 40.79%
Jun 30, 2023 46.15%
Mar 31, 2023 127.08%
Dec 31, 2022 -1,138.71%
Sep 30, 2022 -156.36%
Jun 30, 2022 1,733.33%
Mar 31, 2022 105.56%
Dec 31, 2021 37.21%
Sep 30, 2021 85.92%
Jun 30, 2021 -392.34%
Mar 31, 2021 -10.30%
Dec 31, 2020 -11.74%
Sep 30, 2020 28.16%
Jun 30, 2020 173.05%
Mar 31, 2020 -318.60%
Dec 31, 2019 -27.53%
Sep 30, 2019 -60.96%
Jun 30, 2019 210.20%
Mar 31, 2019 -44.32%
Dec 31, 2018 9.54%
Sep 30, 2018 60.67%
Jun 30, 2018 100.00%
Mar 31, 2018 -80.21%
Dec 31, 2017 267.96%
Sep 30, 2017 -40.12%
Jun 30, 2017 21.99%
Mar 31, 2017 -26.18%
Dec 31, 2016 31.72%
Sep 30, 2016 -21.62%
Jun 30, 2016 52.89%
Mar 31, 2016 -8.33%
Dec 31, 2015 -5.04%
Sep 30, 2015 -0.71%
Jun 30, 2015 25.00%
Mar 31, 2015 -13.85%
Dec 31, 2014 217.07%
Sep 30, 2014 -41.43%
Jun 30, 2014 144.30%
Mar 31, 2014 -275.56%
Dec 31, 2013 -26.83%
Sep 30, 2013 78.26%
Jun 30, 2013 -2.82%
Mar 31, 2013 -78.35%
Dec 31, 2012 496.36%
Sep 30, 2012 22.22%
Jun 30, 2012 -6.25%
Mar 31, 2012 -39.24%
Dec 31, 2011 14.49%
Sep 30, 2011 -2.82%
Jun 30, 2011 47.92%
Mar 31, 2011 -21.31%
Dec 31, 2010 -11.59%
Sep 30, 2010 -2.82%